Department of Genomic Medicine
In the past, the field of genetics—under the name clinical genetics—primarily focused on the diagnosis and treatment of hereditary diseases caused by mutations in a single gene. Today, however, genomic medicine goes beyond individual genes to analyze the entire genome through comprehensive testing and big data analysis. This enables the prediction, prevention, and accurate diagnosis of diseases, as well as the development of personalized treatments. Furthermore, genomic medicine plays a critical role in assessing familial disease risks, helping to protect the health of entire families. It represents the future of medicine.
The Department of Clinical Genomic Medicine at Seoul National University Bundang Hospital was newly established in April 2024 to tackle serious illnesses such as cancer and rare, intractable diseases, and to realize a new paradigm in precision and integrative medicine.
The department aims to systematically manage genomic testing and consultations, which were previously conducted separately across multiple clinical departments.
In addition, the department engages in diverse research efforts, including cancer genomics, the diagnosis and mechanistic study of rare diseases, and the development of gene therapies and new pharmaceuticals. It also strives to cultivate medical professionals with specialized expertise in genomics, with the goal of leading the future of advanced medical science.
.png
)
